MARY GRACE TOLENTINO: Open Payments
NPI 1578000550 · TEANECK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,857 in 45 payments from 12 companies in 2025. Trend: 2023 $2,243 · 2024 $1,980 · 2025 $1,857
Food & beverage: $1,857
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 14 | $605 |
| Amgen Inc. | 12 | $381 |
| Novo Nordisk Inc | 4 | $163 |
| Madrigal Pharmaceuticals | 1 | $145 |
| Janssen Biotech, Inc. | 1 | $137 |
| Phathom Pharmaceuticals, Inc. | 1 | $125 |
| ABIOMED | 1 | $113 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $66 |
| Intra-Sana Laboratories | 3 | $47 |
| Lilly USA, LLC | 2 | $39 |
Products named: REPATHA, AIRSUPRA, BREZTRI, REZDIFFRA, Wegovy, TREMFYA, VOQUEZNA, OTEZLA.
Industry payments across NJ — which companies pay providers there.
